Protective effects of lotus plumule ethanol extracts on bleomycin-induced pulmonary fibrosis in mice

References

• Chen, C., et al., 2015. Effect of three-dimensional acellular fibrotic lung matrices on fibroblast-to-myofibroblast differentiation. Zhonghua Yi Xue Za Zhi, 95 (46), 3753–3757.
   PubMedGoogle Scholar
• Chen, M.S., et al., 2015. Anti-fibrotic effects of neferine on carbon tetrachloride-induced hepatic fibrosis in mice. The American Journal of Chinese Medicine, 43 (2), 231–240.
   PubMed Web of Science ®Google Scholar
• Chen, W., et al., 2019. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation. Theranostics, 9 (14), 3980–3991.
   PubMed Web of Science ®Google Scholar
• Conte, E., et al., 2014. Thymosin β4 reduces IL-17-producing cells and IL-17 expression, and protects lungs from damage in bleomycin-treated mice. Immunobiology, 219 (6), 425–431.
   PubMed Web of Science ®Google Scholar
• Ding, S., et al., 2019. Resveratrol alleviates chronic "real-world" ambient particulate matter-induced lung inflammation and fibrosis by inhibiting NLRP3 inflammasome activation in mice. Ecotoxicology and Environmental Safety, 182, 109425.
   PubMed Web of Science ®Google Scholar
• Distler, J., et al., 2019. Shared and distinct mechanisms of fibrosis. Nature Reviews. Rheumatology, 15 (12), 705–730.
   PubMed Web of Science ®Google Scholar
• Francois, A., et al., 2015. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis. Journal of Autoimmunity, 56, 1–11.
   PubMed Web of Science ®Google Scholar
• Gao, Y., et al., 2016. The Chinese herbal medicine formula mKG suppresses pulmonary fibrosis of mice induced by bleomycin. International Journal of Molecular Sciences, 17 (2), 238–251.
   PubMed Web of Science ®Google Scholar
• George, P.M., Wells, A.U., and Jenkins, R.G., 2020. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet. Respiratory Medicine, 8 (8), 807–815.
   PubMed Web of Science ®Google Scholar
• Hao, Y. and Liu, Y., 2016. Osthole alleviates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/angiotensin-(1–7) axis and decreasing inflammation responses in rats. Biological & Pharmaceutical Bulletin, 39 (4), 457–465.
   PubMed Web of Science ®Google Scholar
• He, N., et al., 2019. Evaluation of glutathione S-transferase inhibition effects on idiopathic pulmonary fibrosis therapy with a near-infrared fluorescent probe in cell and mice models. Analytical Chemistry, 91 (8), 5424–5432.
   PubMed Web of Science ®Google Scholar
• Hu, H.H., et al., 2018. New insights into TGF-β/Smad signaling in tissue fibrosis. Chemico-Biological Interactions, 292, 76–83.
   PubMed Web of Science ®Google Scholar
• Hu, L., et al., 2021. Chemical profile of Cimicifuga heracleifolia Kom. and immunomodulatory effect of its representative bioavailable component, cimigenoside on poly(I:C)-induced airway inflammation. Journal of Ethnopharmacology, 267, 113615.
   PubMed Web of Science ®Google Scholar
• Huang, C., et al., 2014. IL-17A promotes pulmonary inflammation in rats with pulmonary fibrosis induced by bleomycin. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 30 (4), 366–370.
   PubMedGoogle Scholar
• Huang, X., et al., 2016. Decitabine and 5-azacitidine both alleviate LPS induced ARDS through anti-inflammatory/antioxidant activity and protection of glycocalyx and inhibition of MAPK pathways in mice. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 84, 447–453.
   PubMed Web of Science ®Google Scholar
• Jiang, Y., et al., 2018. An integrated strategy to rapidly characterize non-targeted benzylisoquinoline alkaloids from Plumula nelumbinis ethanol extract using UHPLC/Q-orbitrap HRMS. International Journal of Mass Spectrometry, 432, 26–35.
   Web of Science ®Google Scholar
• Kato, E., Inagaki, Y., and Kawabata, J., 2015. Higenamine 4′-O-β-d-glucoside in the lotus plumule induces glucose uptake of L6 cells through β2-adrenergic receptor. Bioorganic & Medicinal Chemistry, 23 (13), 3317–3321.
   PubMed Web of Science ®Google Scholar
• Kim, E.A., et al., 2019. Neferine-induced apoptosis is dependent on the suppression of Bcl-2 expression via downregulation of p65 in renal cancer cells. Acta Biochimica et Biophysica Sinica, 51 (7), 734–742.
   PubMed Web of Science ®Google Scholar
• Klee, S., et al., 2016. WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts. Scientific Reports, 6, 20547.
   PubMed Web of Science ®Google Scholar
• Kulkarni, T., et al., 2016. Matrix remodeling in pulmonary fibrosis and emphysema. American Journal of Respiratory Cell and Molecular Biology, 54 (6), 751–760.
   PubMed Web of Science ®Google Scholar
• Kloth, C., et al., 2019. Flow cytometric analysis of the leukocyte landscape during bleomycin-induced lung injury and fibrosis in the rat. American Journal of Physiology. Lung Cellular and Molecular Physiology, 317 (1), L109–L126.
   PubMed Web of Science ®Google Scholar
• Kolb, M., Bonella, F., and Wollin, L., 2017. Therapeutic targets in idiopathic pulmonary fibrosis. Respiratory Medicine, 131, 49–57.
   PubMed Web of Science ®Google Scholar
• Kral, J.B., et al., 2016. Sustained PI3K activation exacerbates BLM-induced lung fibrosis via activation of pro-inflammatory and pro-fibrotic pathways. Scientific Reports, 7, 26048.
   PubMed Web of Science ®Google Scholar
• Kyung, S.Y., et al., 2018. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. BMC Pharmacology & Toxicology, 19 (1), 13.
   PubMed Web of Science ®Google Scholar
• Lei, L., et al., 2016. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Clinical and Experimental Rheumatology, 34 Suppl.100 (5), 14–22.
   PubMed Web of Science ®Google Scholar
• Li, D., et al., 2018. Therapeutic effect of ulinastatin on pulmonary fibrosis via downregulation of TGF-β1, TNF-α and NF-κB. Molecular Medicine Reports, 17 (1), 1717–1723.
   PubMed Web of Science ®Google Scholar
• Lin, Z., et al., 2014. Ultra-performance LC separation and quadrupole time-of-flight MS identification of major alkaloids in Plumula nelumbinis. Phytochemical Analysis, 25 (6), 485–494.
   PubMed Web of Science ®Google Scholar
• Liu, B., et al., 2019. Protective effect of the traditional Chinese patent medicine Qing-Xuan granule against bleomycin-induced pulmonary fibrosis in mice. Chemistry & Biodiversity, 16 (12), e1900467.
   PubMed Web of Science ®Google Scholar
• Lutz, D., et al., 2015. Alveolar derecruitment and collapse induration as crucial mechanisms in lung injury and fibrosis. American Journal of Respiratory Cell and Molecular Biology, 52 (2), 232–243.
   PubMed Web of Science ®Google Scholar
• Mack, M., 2018. Inflammation and fibrosis. Matrix Biology, 68–69, 106–121.
   PubMed Web of Science ®Google Scholar
• Niu, C.H., et al., 2013. Protective effects of neferine on amiodarone-induced pulmonary fibrosis in mice. European Journal of Pharmacology, 714 (1–3), 112–119.
   PubMed Web of Science ®Google Scholar
• Paudel, K.R. and Panth, N., 2015. Phytochemical profile and biological activity of Nelumbo nucifera. Evidence-Based Complementary and Alternative Medicine, 2015, 789124.
   PubMed Web of Science ®Google Scholar
• Raghu, G., 2017. Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years. European Respiratory Journal, 50 (4), 1701209.
   PubMed Web of Science ®Google Scholar
• Ravanetti, F., et al., 2020. Modeling pulmonary fibrosis through bleomycin delivered by osmotic minipump: a new histomorphometric method of evaluation. American Journal of Physiology. Lung Cellular and Molecular Physiology, 318 (2), L376–L385.
   PubMed Web of Science ®Google Scholar
• Richeldi, L., Collard, H.R., and Jones, M.G., 2017. Idiopathic pulmonary fibrosis. The Lancet, 389 (10082), 1941–1952.
   PubMed Web of Science ®Google Scholar
• Russell, A.M., Ripamonti, E., and Vancheri, C., 2016. Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients' perspectives of the disease and treatment. BMC Pulmonary Medicine, 16, 10.
   PubMed Web of Science ®Google Scholar
• Shariati, S., et al., 2019. Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 114, 108776.
   PubMed Web of Science ®Google Scholar
• Stout-Delgado, H.W., et al., 2016. Age-dependent susceptibility to pulmonary fibrosis is associated with NLRP3 inflammasome activation. American Journal of Respiratory Cell and Molecular Biology, 55 (2), 252–263.
   PubMed Web of Science ®Google Scholar
• Sun, G.D., et al., 2019. Identification and characterization of major chemical compounds in Sophorae fructus based on UPLC-Q-TOF/MS. Chinese Traditional and Herbal Drugs. 50 (8), 3774–3783.
   Google Scholar
• Sun, Q., et al., 2019. Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/Smad signaling pathway. Experimental Lung Research, 45 (5–6), 123–134.
   PubMed Web of Science ®Google Scholar
• Szapiel, S.V., et al., 1979. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. The American Review of Respiratory Disease, 120 (4), 893–899.
   PubMed Web of Science ®Google Scholar
• Tang, G.X., et al., 2007. Protective effects of isoliensinine on acute lung injury and pulmonary fibrosis induced by paraquat. Chinese Journal of Pharmacology & Toxicology, 21 (6), 462–469.
   Google Scholar
• Tang, Y.J., et al., 2014. Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice. American Journal of Respiratory Cell and Molecular Biology, 51 (6), 761–771.
   PubMed Web of Science ®Google Scholar
• Tian, W., et al., 2018. Chemical composition of alkaloids of Plumula nelumbinis and their antioxidant activity from different habitats in China. Industrial Crops and Products, 125, 537–548.
   Web of Science ®Google Scholar
• Trajano, L.A., et al., 2016. Elastase modifies bleomycin-induced pulmonary fibrosis in mice. Acta Histochemica, 118 (3), 203–212.
   PubMed Web of Science ®Google Scholar
• Uehara, A., et al., 2016. Mechanistic insight into the norepinephrine-induced fibrosis in systemic sclerosis. Scientific Reports, 6, 34012.
   PubMed Web of Science ®Google Scholar
• Vaidya, B., et al., 2017. Exploitation of novel molecular targets to treat idiopathic pulmonary fibrosis: a drug discovery perspective. Current Medicinal Chemistry, 24 (22), 2439–2458.
   PubMed Web of Science ®Google Scholar
• Wang, T., et al., 2017. Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-beta1 mediated Smad2/3 and ERK1/2 activation. PLOS One, 12 (9), e183972.
   Web of Science ®Google Scholar
• Wang, Q., et al., 2018. Genome-wide transcriptional changes in type 2 diabetic mice supplemented with lotus seed resistant starch. Food Chemistry, 264, 427–434.
   PubMed Web of Science ®Google Scholar
• Weber, C. and Hristov, M., 2015. Atherogenesis and inflammation. From cellular mediators to regulatory mechanisms of inflammation in atherosclerosis. Hämostaseologie, 35 (2), 99–101.
   PubMed Web of Science ®Google Scholar
• Williams, K. and Roman, J., 2016. Studying human respiratory disease in animals—role of induced and naturally occurring models. The Journal of Pathology, 238 (2), 220–232.
   PubMed Web of Science ®Google Scholar
• Yasar, Z. and Cetinkaya, E., 2015. Current management of idiopathic pulmonary fibrosis. Tüberküloz ve Toraks, 63 (4), 278–290.
   PubMed Web of Science ®Google Scholar
• Ye, Q., et al., 2014. Prevention of pulmonary fibrosis via trichostatin A (TSA) in bleomycin induced rats. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 31 (3), 219–226.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.F., et al., 2020. A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 126, 109907.
   PubMed Web of Science ®Google Scholar
• Zhou, X., et al., 2014. Inhibitory effects of hydrogen sulphide on pulmonary fibrosis in smoking rats via attenuation of oxidative stress and inflammation. Journal of Cellular and Molecular Medicine, 18 (6), 1098–1103.
   PubMed Web of Science ®Google Scholar
• Zhou, Z., et al., 2019. Hesperidin ameliorates bleomycin-induced experimental pulmonary fibrosis via inhibition of TGF-beta1/Smad3/AMPK and IkappaBalpha/NF-kappaB pathways. EXCLI Journal, 29 (18), 723–745.
   Google Scholar